title: [Esthesioneuroblastoma treatment].
abstract: BACKGROUND
  Esthesioneuroblastoma is an uncommon malignancy of the olfactory neuroepithelium. The best treatment has yet to be defined. The purpose of this study is to analyze the tumors's behaviour to choose the ideal treatment, the therapeutic strategy and the patterns of failure.
  
  
  METHODS
  We carry out a revision of the series published between 1994 to 2004. In these series, we found 39 papers with 713 patients.
  
  
  CONCLUSIONS
  
  
  
  CONCLUSIONS
  In this review the 5-years survival rate is 51.2%. Through the analysis of 583 partients found in 34 publications, surgery (alone or combined) is the treatment most used (78%). The commonly management is surgical in combination with radiotherapy (47%).
authors.affiliation: Cátedra de Otorrinolaringología, Departamento de Cirugía, Servicio de ORL y PCF, Hospital Universitario Rio Hortega, Universidad de Valladolid, SACYL. elisagilcarcedo@wanadoo.es
authors.forename: E
authors.initials: E
authors.lastname: Gil-Carcedo
authors.forename: L M
authors.initials: LM
authors.lastname: Gil-Carcedo
authors.forename: L A
authors.initials: LA
authors.lastname: Vallejo
authors.forename: J M
authors.initials: JM
authors.lastname: de Campos
mesh_terms: D018304:Esthesioneuroblastoma, Olfactory / Q000628:therapy*; D006801:Humans; D009296:Nasal Cavity; D009669:Nose Neoplasms / Q000628:therapy*